Using machine learning algorithms to identify genes essential for cell survival
暂无分享,去创建一个
Heng-Yi Wu | Lang Li | Santosh Philips | Lang Li | S. Philips | Lang Li | Heng-Yi Wu
[1] D. Swanson. Medical literature as a potential source of new knowledge. , 1990, Bulletin of the Medical Library Association.
[2] H. Grabsch,et al. EphB2 is a Prognostic Factor in Colorectal Cancer , 2005, Clinical Cancer Research.
[3] J. Brugge,et al. Distinct roles of Akt1 and Akt2 in regulating cell migration and epithelial–mesenchymal transition , 2005, The Journal of cell biology.
[4] S. Cory,et al. The Bcl-2 protein family: arbiters of cell survival. , 1998, Science.
[5] R. Figlin,et al. Akt inhibitors in clinical development for the treatment of cancer , 2010, Expert opinion on investigational drugs.
[6] R. Hotchkiss,et al. Cell death. , 2009, The New England journal of medicine.
[7] R. Tibshirani,et al. Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[8] J. Testa,et al. AKT signaling in normal and malignant cells , 2005, Oncogene.
[9] D. Hunter. Gene–environment interactions in human diseases , 2005, Nature Reviews Genetics.
[10] Flore Kruiswijk,et al. p53 in survival, death and metabolic health: a lifeguard with a licence to kill , 2015, Nature Reviews Molecular Cell Biology.
[11] T. Vanden Berghe,et al. Major cell death pathways at a glance. , 2009, Microbes and infection.
[12] F. Jiggins,et al. The evolution of RNAi as a defence against viruses and transposable elements , 2008, Philosophical Transactions of the Royal Society B: Biological Sciences.
[13] Martin Kuiper,et al. Biological knowledge management: the emerging role of the Semantic Web technologies , 2009, Briefings Bioinform..
[14] A. Fire,et al. Specific inhibition of gene expression by small double-stranded RNAs in invertebrate and vertebrate systems , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[15] S. Ding,et al. Induction and Suppression of RNA Silencing by an Animal Virus , 2002, Science.
[16] Hemant K Roy,et al. AKT proto-oncogene overexpression is an early event during sporadic colon carcinogenesis. , 2002, Carcinogenesis.
[17] P. Gorman,et al. A taxonomy of generic clinical questions: classification study , 2000, BMJ : British Medical Journal.
[18] H. Kohrt,et al. Therapeutic antitumor immunity by checkpoint blockade is enhanced by ibrutinib, an inhibitor of both BTK and ITK , 2015, Proceedings of the National Academy of Sciences.
[19] R. Lothe,et al. Three Epigenetic Biomarkers, GDF15, TMEFF2, and VIM, Accurately Predict Bladder Cancer from DNA-Based Analyses of Urine Samples , 2010, Clinical Cancer Research.
[20] T. Tuschl,et al. RNA Interference and Small Interfering RNAs , 2001, Chembiochem : a European journal of chemical biology.
[21] Steven J. M. Jones,et al. Comprehensive molecular portraits of human breast tumours , 2013 .
[22] A. Lykkesfeldt,et al. Antiestrogen-resistant human breast cancer cells require activated protein kinase B/Akt for growth. , 2005, Endocrine-related cancer.
[23] Ya-hong Zhang,et al. Distinct roles of Akt1 in regulating proliferation, migration and invasion in HepG2 and HCT 116 cells. , 2014, Oncology reports.
[24] Y. Shim,et al. Lung cancer in never-smoker Asian females is driven by oncogenic mutations, most often involving EGFR , 2015, Oncotarget.
[25] Wei Liu,et al. EphB2 promotes cervical cancer progression by inducing epithelial-mesenchymal transition. , 2014, Human pathology.
[26] Christian A. Rees,et al. Molecular portraits of human breast tumours , 2000, Nature.
[27] M. Hahne,et al. Cell Death , 2010, Cell Death and Differentiation.
[28] C. Sawyers,et al. The phosphatidylinositol 3-Kinase–AKT pathway in human cancer , 2002, Nature Reviews Cancer.
[29] D. Swanson. Fish Oil, Raynaud's Syndrome, and Undiscovered Public Knowledge , 2015, Perspectives in biology and medicine.
[30] K. Hibi,et al. Serum vimentin methylation as a potential marker for colorectal cancer. , 2014, Anticancer research.
[31] R. Glazer,et al. Role of AKT1 in 17beta-estradiol- and insulin-like growth factor I (IGF-I)-dependent proliferation and prevention of apoptosis in MCF-7 breast carcinoma cells. , 1999, Biochemical pharmacology.
[32] R. Versteeg,et al. Targeted BIRC5 silencing using YM155 causes cell death in neuroblastoma cells with low ABCB1 expression. , 2012, European journal of cancer.
[33] Amy A. Caudy,et al. Post-transcriptional gene silencing by double-stranded RNA , 2001, Nature Reviews Genetics.
[34] Kei-Hoi Cheung,et al. Advancing translational research with the Semantic Web , 2007, BMC Bioinformatics.
[35] D. A. Schwartz. The importance of gene–environment interactions and exposure assessment in understanding human diseases , 2006, Journal of Exposure Science and Environmental Epidemiology.
[36] Steven J. M. Jones,et al. Comprehensive molecular portraits of human breast tumors , 2012, Nature.
[37] J. LoPiccolo,et al. Targeting the PI3K/Akt/mTOR pathway: effective combinations and clinical considerations. , 2008, Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy.
[38] Don R. Swanson,et al. Two medical literatures that are logically but not bibliographically connected , 1987, J. Am. Soc. Inf. Sci..
[39] Lewis C. Cantley,et al. AKT/PKB Signaling: Navigating Downstream , 2007, Cell.
[40] Leo Eberl,et al. Essence of life: essential genes of minimal genomes. , 2011, Trends in cell biology.
[41] Aleix Prat Aparicio. Comprehensive molecular portraits of human breast tumours , 2012 .
[42] Anjana Rao,et al. NFAT, immunity and cancer: a transcription factor comes of age , 2010, Nature Reviews Immunology.
[43] T. Furukawa,et al. The BAX gene, the promoter of apoptosis, is mutated in genetically unstable cancers of the colorectum, stomach, and endometrium. , 1998, Clinical cancer research : an official journal of the American Association for Cancer Research.
[44] T. Tuschl,et al. Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells , 2001, Nature.
[45] Faye M. Johnson,et al. Regulation of Src Family Kinases in Human Cancers , 2011, Journal of signal transduction.
[46] M. Manoharan. RNA interference and chemically modified small interfering RNAs. , 2004, Current opinion in chemical biology.
[47] Peter Carmeliet,et al. VEGF as a Key Mediator of Angiogenesis in Cancer , 2005, Oncology.
[48] F. Graziano,et al. The role of the E-cadherin gene (CDH1) in diffuse gastric cancer susceptibility: from the laboratory to clinical practice. , 2003, Annals of oncology : official journal of the European Society for Medical Oncology.
[49] P. Sharp,et al. RNA interference--2001. , 2001, Genes & development.
[50] David L. Lewis,et al. Efficient delivery of siRNA for inhibition of gene expression in postnatal mice , 2002, Nature Genetics.
[51] S. R. Datta,et al. Cellular survival: a play in three Akts. , 1999, Genes & development.
[52] R. Eisenman,et al. Stress-induced cleavage of Myc promotes cancer cell survival , 2014, Genes & development.
[53] A. Toker,et al. NFAT proteins: emerging roles in cancer progression , 2009, Nature Reviews Cancer.
[54] Enrique Casado,et al. PI3K/Akt signalling pathway and cancer. , 2004, Cancer treatment reviews.
[55] Ian H. Witten,et al. Data mining in bioinformatics using Weka , 2004, Bioinform..
[56] M. Pan,et al. NFAT gene family in inflammation and cancer. , 2013, Current molecular medicine.
[57] A. Fire,et al. RNA-triggered gene silencing. , 1999, Trends in genetics : TIG.
[58] Suzanne Cory,et al. The Bcl-2 family: roles in cell survival and oncogenesis , 2003, Oncogene.
[59] Olivier Voinnet,et al. Antiviral Immunity Directed by Small RNAs , 2007, Cell.
[60] J. Harmey,et al. Angiogenic and cell survival functions of Vascular Endothelial Growth Factor (VEGF) , 2005, Journal of cellular and molecular medicine.
[61] Liang Wang,et al. AHSA1 regulates proliferation, apoptosis, migration, and invasion of osteosarcoma. , 2016, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.
[62] S. Bao,et al. The activation of Akt/PKB signaling pathway and cell survival , 2005, Journal of cellular and molecular medicine.
[63] Don R. Swanson,et al. Online search for logically-related noninteractive medical literatures: A systematic trial-and-error strategy , 1989, JASIS.
[64] J. Testa,et al. Perturbations of the AKT signaling pathway in human cancer , 2005, Oncogene.
[65] Don R. Swanson,et al. A second example of mutually isolated medical literatures related by implicit, unnoticed connections , 1989, JASIS.
[66] Ricardo Almeida,et al. RNA silencing and genome regulation. , 2005, Trends in cell biology.
[67] N. Pećina-Šlaus. Tumor suppressor gene E-cadherin and its role in normal and malignant cells , 2003, Cancer Cell International.
[68] P. Gorman,et al. Clinical questions raised by clinicians at the point of care: a systematic review. , 2014, JAMA internal medicine.
[69] M. Merad,et al. CDKN1A regulates Langerhans cell survival and promotes Treg cell generation upon exposure to ionizing irradiation , 2015, Nature Immunology.
[70] F. Eusebi,et al. Cyclin D1 degradation enhances endothelial cell survival upon oxidative stress , 2006, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[71] Arnold J Levine,et al. p53 regulates cell survival by inhibiting PIK3CA in squamous cell carcinomas. , 2002, Genes & development.
[72] Osamu Hori,et al. Cellular Stress Responses: Cell Survival and Cell Death , 2010, International journal of cell biology.
[73] R. Glazer,et al. Role of AKT1 in 17β-estradiol- and insulin-like growth factor I (IGF-I)-dependent proliferation and prevention of apoptosis in MCF-7 breast carcinoma cells , 1999 .
[74] W. Alexander,et al. Inhibiting the akt pathway in cancer treatment: three leading candidates. , 2011, P & T : a peer-reviewed journal for formulary management.
[75] M. Ellis,et al. A Phase I Study of the AKT Inhibitor MK-2206 in Combination with Hormonal Therapy in Postmenopausal Women with Estrogen Receptor–Positive Metastatic Breast Cancer , 2016, Clinical Cancer Research.
[76] Jie Zhou,et al. Akt1 governs breast cancer progression in vivo , 2007, Proceedings of the National Academy of Sciences.
[77] N. Normanno,et al. Epidermal growth factor receptor (EGFR) signaling in cancer. , 2006, Gene.
[78] J. Chen,et al. Unraveling human complexity and disease with systems biology and personalized medicine. , 2010, Personalized medicine.
[79] A. Nobel,et al. Supervised risk predictor of breast cancer based on intrinsic subtypes. , 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[80] J. Manfredi,et al. p53 Promotes Cell Survival due to the Reversibility of Its Cell-Cycle Checkpoints , 2014, Molecular Cancer Research.
[81] Amos Bairoch,et al. The Cellosaurus, a Cell-Line Knowledge Resource. , 2018, Journal of biomolecular techniques : JBT.
[82] D. Swanson. Literature-based Resurrection of Neglected Medical Discoveries , 2011, Journal of biomedical discovery and collaboration.